Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (682K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (121)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Mian, I. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mian, I. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 Oxford University Press 3187-3195

Comparative sequence analysis of ribonucleases HII, III, II, PH and D

Comparative sequence analysis of ribonucleases HII, III, II, PH and D I. Saira Mian*

Sinsheimer Laboratories, University of California Santa Cruz, Santa Cruz, CA 95064, USA and Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA

Received March 19, 1997; Revised and Accepted May 29, 1997

ABSTRACT

Escherichia coli ribonucleases (RNases) HII, III, II, PH and D have been used to characterise new and known viral, bacterial, archaeal and eucaryotic sequences similar to these endo- (HII and III) and exoribonucleases (II, PH and D). Statistical models, hidden Markov models (HMMs), were created for the RNase HII, III, II, PH and D families as well as a double-stranded RNA binding domain present in RNase III. Results suggest that the RNase D family, which includes Werner syndrome protein and the 100 kDa antigenic component of the human polymyositis scleroderma (PMSCL) autoantigen, is a 3' -> 5' exoribonuclease structurally and functionally related to the 3' -> 5' exodeoxyribonuclease domain of DNA polymerases. Polynucleotide phosphorylases and the RNase PH family, which includes the 75 kDa PMSCL autoantigen, possess a common domain suggesting similar structures and mechanisms of action for these 3' -> 5' phosphorolytic enzymes. Examination of HMM-generated multiple sequence alignments for each family suggest amino acids that may be important for their structure, substrate binding and/or catalysis.

INTRODUCTION

As the details of RNA metabolism have emerged, there has been a concomitant increase in interest in the enzymes that carry out these events. Although it has been suggested that proteasomes, multiprotein complexes involved in processing and turnover of cellular proteins, could also be involved in cellular RNA breakdown and RNA processing (1 ), one group of enzymes has long been known to be important in such events. Ribonucleases (RNases) are enzymes involved in many functions such as RNA processing, stability, turnover and degradation (reviewed in 2 ,3 ). For example, mRNA stability influences gene expression in virtually all organisms from bacteria to mammals and the abundance of a particular mRNA can fluctuate manyfold following a change in the messenger RNA (mRNA) half-life without any alteration in transcription (reviewed in 4 ). Another testament to the general importance of these enzymes is evidence that self-incompatibility in flowering plants involves an RNase (reviewed in 5 ,6 ).

The focus of this work is identification and characterisation of new and known viral, bacterial, archaeal and eucaryotic sequences similar to Escherichia coli RNases HII, III, II, PH and D using the recently developed statistical modelling method of hidden Markov models (HMMs) (7 -10 ). A double-stranded (ds) RNA binding domain present in RNase III is examined also. An HMM of the type created and used here is a sequence of nodes in which each node corresponds to a column in a multiple sequence alignment for a family of related sequences. The HMM technique allows identification, modelling and analysis of the core elements of a family likely to be determinants of the folding, structure and function of that family. For the RNases examined here, the results can provide guidance for further experimental and theoretical work as well as insights into the relationships within and between the different families.

RNases HII, III (also called RNase C), II (also called RNase B), PH and D were selected for study because of their important roles in many organisms (reviewed in 2 ,3 ,11 ,12 ). In particular, they act on a wide spectrum of substrates and include both endo- (HII and III) and exoribonucleases (II, PH and D). RNase HII degrades the RNA moiety of RNA-DNA hybrids (13 ,14 ). Processing of ribosomal RNA precursors (pre-rRNAs) and of some mRNAs requires the ds specific RNase III (15 ). RNase PH is both a phosphorolytic nuclease that removes nucleotides following the CCA terminus of tRNA and a nucleotidyltransferase which adds nucleotides to the ends of RNA molecules by using nucleoside diphosphates as substrates (16 ,17 ). RNase II and polynucleotide phosphorylase (PNPase) are the two principal nucleases involved in processive 3' -> 5' degradation of single-stranded (ss) mRNA (see, for example, ref. 18 ). RNases II, PH and D are three of at least five 3' -> 5' nucleases required for 3' processing of tRNA precursors (pre-tRNAs) (12 ,19 ). A number of these RNases also have a role in the efficacy of some therapeutic molecules. Antisense agents such as antisense oligonucleotides and ribozymes bind to DNA or RNA sequences and block the synthesis of cellular or viral proteins by interfering with transcription and translation (reviewed in 20 ). Antisense oligonucleotides form stable duplexes that are substrates for cleavage by RNase H, which, like RNase HII, acts on RNA-DNA duplexes. In addition, RNase II and PNPase appear to be the major nucleases that degrade hammerhead ribozymes (21 ) as well as RNA-OUT, a 69 nucleotide antisense RNA that regulates Tn10/IS10 transposition (22 ). Thus, studies of these RNases may yield insights into intracellular degradation of foreign RNAs and subsequent development of more stable ribozymes and antisense molecules. Furthermore, the five RNase families examined here provide a glimpse into the myriad of roles that RNases play in how cells grow, differentiate and respond to their environment.

METHODS

Escherichia coli RNases HII, III, II, PH and D were used as query sequences in database searches performed with the BLAST suite of programs (23 ) run with default parameters and a merged, non-redundant collection of sequences derived from PIR, SwissProt and translated GenBank. Database sequences were considered to exhibit a statistically significant similarity to the query if the smallest sum probability P(N) <= 0.05, P(N) being the lowest probability ascribed to any set of high scoring segment pairs for each database sequence. Partial sequences, fragments and expressed sequence tags (ESTs) identified by these BLAST database searches were retained but not employed for HMM training and database discrimination experiments. HMMs were trained for proteins belonging to the RNase HII, III, II, PH and D families as well as a ds RNA binding domain present in RNase III by the procedure outlined below.

An HMM was created using the SAM (Sequence Alignment and Modeling Software System) suite (7 ,24 ) running on a MASPAR MP-2204 with a DEC Alpha 3000/300X frontend at the University of California Santa Cruz (UCSC). In an HMM, use of a match state indicates that a sequence has a residue in that column whereas using a delete state denotes that the sequence does not. Insert states allow sequences to have additional residues between columns and represent regions of the sequence that are not part of the core elements of the family being modelled. To improve the ability of the HMM to generalise, to fit sequences not employed for training, Dirichlet mixture priors (25 ,26 ) were employed. Free Insertion Modules (FIMs) were utilised to allow the HMM to model a region or motif within a larger sequence. Multiple models were trained and the best used for further studies.

Any sequence can be compared to a model by calculating the likelihood that the sequence was generated by that model. Taking the negative (natural) logarithm of this likelihood gives the NLL score. For sequences of equal length, the NLL scores measures how `far' they are from the model and can be used to select sequences from the same family. To assess the specificity and sensitivity of an HMM, it can be used in database discrimination experiments to distinguish between sequences that belong to the family used to train it from those that do not. The programme hmmscore was used to evaluate how much better a sequence fits a model than some underlying background distribution or null model (NULL) and to assess the significance of the resultant score. Database searching using the HMM involves computing log-odds (NLL-NULL) (27 ,28 ) scores for all sequences in a non-redundant protein database obtained from the NCI (29 ) and updated weekly at UCSC. Taking into account the number of sequences in this database (~211 000 different proteins in late 1996) and an expected number of false positives of 0.01, a significant log-odds score is 22.6. Scores higher than this value denote fewer expected false positives. A database search was performed and based upon examination of the log-odds scores and an HMM-generated alignment, new family members were identified, added to the training set and the HMM retrained. This cycle of `search, align and retrain' was repeated until no new sequences were identified in databases up to December 1996. This final HMM was utilised to generate a multiple sequence alignment of the final training set and the partial sequences retained from the initial BLAST searches.

RESULTS

An aim of this study was to train and use HMMs that minimised the numbers of false positives and false negatives. Amongst ~211 000 different proteins, sequences that were not part of their respective training set had log-odds scores <15.0 whereas training set sequences had scores >31.0 (RNase HII), >25.0 (RNase III), >27.2 (ds RNA binding domain), >60.4 (RNase II), >26.6 (RNase PH) and >21.1 (RNase D). For all six families, inspection of the HMM-generated alignments and examination of the log-odds scores suggested there were no false positives amongst sequences with log-odds scores >21.1 and that such sequences could be classified as being members of the family being modelled. However, it cannot be assumed that there are no false negatives amongst sequences with log-odds scores <15.0. There may be remote homologues that have diverged to a degree that the current HMMs may be too specific (overfit the data) and thus unable to classify them as belonging to a particular family. Further generalisation of the HMMs is required to detect such distant family members.

HMM-generated multiple alignments of members of the six families examined are shown in Figures 1 -6 which were produced using ALSCRIPT (30 ). [sect] denotes new members of a family identified here and [Dagger] partial sequences retained from BLAST searches but not employed for HMM training. Existing members of the RNase III (15 ,31 ,32 ), ds RNA binding domain (33 ,34 ) and RNase II (35 -40 ) families have been described elsewhere. Subsequent discussions will focus on new family members. Invariant positions are defined as those residues conserved across all the sequences in an alignment and whose locations are marked by filled triangles. Amino acids conserved in the majority of sequences are highlighted and columns that are predominantly hydrophobic boxed. Columns containing `.' correspond to insert states and numbers indicate the lengths of insertions in sequences at that position (if present).


Figure 1. An HMM-generated multiple sequence alignment for RNase HII family members from bacteria [1-10], an archaeon [11] and eucarya [12-16]. 1:Ec_RNHII E.coli RNase HII (RNH2_ECOLI); 2:St_RNHII[Dagger] Salmonella typhimurium RNase HII (RNH2_SALTY); 3:Hi_RNHII Haemophilus influenzae RNase HII (RNH2_HAEIN); 4:Vc_RNHII[Dagger] Vibrio cholerae RNase HII (VCU30472); 5:Cc_RNHII Caulobacter crescentus RNase HII (S76857); 6:Pg_RNHII[Dagger] Porphyromonas gingivalis RNase HII (PGPGAAGEN); 7:Mc_RNHII[Dagger] Mycoplasma capricolum RNase HII (S46901); 8:Mt_RNHII Mycobacterium tuberculosis RNase HII (MTCY274); 9:Mg_RNHII Magnetospirillum sp.RNase HII (MGNMAGA); 10:S._RNHII Synechocystis sp.PCC6803 RNase HII (D90899); 11:Mj_RNHII M.jannaschii RNase HII (MJU67470); 12:Sc_N2369[sect] S.cerevisiae ORF N2369 (S53908); 13:Sp_C4G902[sect] S.pombe ORF SPAC4G9.02 (SPAC4G9); 14:Ce_T13H52[sect] C.elegans ORF T13H5.2 (CET13H5); 15:Mm_ESTs[sect][Dagger] Mus musculus ESTs (W71720, W76969); 16:Hs_EST[sect][Dagger] Homo sapiens EST (W05602).

Although all six families have at least one or more yeast (Saccharomyces cerevisiae) and human member, only the RNase HII family has an archaeal member. It is possible that the current suite of proteins predicted to occur in the complete genome of the archaeon Methanococcus jannaschii (41 ) contains no homologues for the five other families. However, it may be that members of these families have diverged to an extent in this archaeon that the current HMMs are too specific and thus unable to detect these remote homologues. Another explantion may be that open reading frames that are family members have not been identified yet and thus would not have appeared in the databases that were searched using the HMMs.

DISCUSSION

Figure 1 shows new eucaryotic RNase HII family members (yeast, 12:Sc_N2369, 13:Sp_C4G902; worm, 14:Ce_T13H52; mammals, 15:Mm_ESTs, 16:Hs_EST). Since RNase HII acts on RNA-DNA duplexes, they may be involved in DNA replication as well as being candidates for mediating the effect of antisense oligonucleotides.

Figure 2 shows new RNase III family members from bacteria (10:My_ORF, 12:Si_ORF) and eucarya (yeast, 16:Sp_C8A4.08C; worm, 17:Ce_K12H4.8, 20:Ce_F26E4.b; mammals 21:Mm_EST, 22:Hs_ESTs). A S.cerevisiae RNase III (RNase RNT1; 18:Sc_RNT1) cleaves pre-rRNA at a U3 snoRNP- dependent site (15 ) suggesting that some of the other eucaryotic sequences may be important in pre-rRNA processing. Schizosaccharomyces pombe and Caenorhabditis elegans each have two RNase III members suggesting involvement in processing different pre-rRNA sites or other RNAs. Three positions in RNase III have been mutated (31 ,42 ,43 ). The first, an invariant Gly (glycine) important for activity in two different sequences, occurs in a highly conserved octapeptide that contains three of the four invariant residues. A second occurs at a variable position. The third is a conserved, functionally important Glu (glutamic acid) present in all RNase III members apart from a bacterium (4:Bs_RNIII) where it is Lys (lysine). In E.coli RNase III, a E -> K,A mutation uncouples substrate binding from cleavage so that it is unclear whether the Bacillus subtilis sequence that has a naturally occuring Lys at this position behaves in a similar manner.


Figure 2. An HMM-generated multiple sequence alignment for RNase III family members from bacteria [1-12, 14 and 15], a virus [13] and eucarya [17-22]. The location of the PROSITE RNase III signature (RIBONUCLEASE_III) and the pattern itself are indicated. Mutations in 1:Ec_RNIII (42,43) and 19:Sp_PAC1 (31) are shown. 1:Ec_RNIII E.coli RNase III (RNC_ECOLI); 2:St_RNIII S.typhimurium RNase III (STU48415); 3:Hi_RNIII H.influenzae RNase III (RNC_HAEIN); 4:Bs_RNIII B.subtilis RNase III (BACORF1G); 5:Cb_RNIII Coxiella burnetii RNase III (COXRER); 6:Rc_RNIII Rhodobacter capsulatus RNase III (RCLEPRNCG); 7:Mt_RNIII M.tuberculosis RNase III (MTCY338); 8:Mg_RNIII Mycoplasma genitalium RNase III (RNC_MYCGE); 9:Mc_RNIII Mycoplasma capricolum RNase III (MC235); 10:My_ORF[sect] Mycoplasma-like organism ORF (obtained by translation of the nucleic acid sequence in a different reading frame to that in MOU15224); 11:Cr_ORF[sect] Cowdria ruminantium ORF (obtained by translation of the nucleic acid sequence in a different reading frame to that in CRPCS20); 12:Si_ORF[sect] Spiroplasma citri ORF orfb (SCU28972); 13:Pc_A464R Paramecium bursaria chlorella virus 1 ORF A464R similar to RNase III (PBU42580); 14:S._RNIII Synechocystis sp. RNase III (SYCSLRB); 15:S._RNIIIb Synechocystis sp.PCC6803 RNase III (D90914); 16:Sp_C8A4.08C[sect] S.pombe hypothetical helicase C8A4.08C (YAH8_SCHPO); 17:Ce_K12H4.8[sect] C.elegans hypothetical helicase K12H4.8 (YM68_CAEEL); 18:Sc_RNT1 S.cerevisiae RNase RNT1 (SCU27016); 19:Sp_PAC1 S.pombe RNase PAC1 (PAC1_SCHPO); 20:Ce_F26E4.b[sect] C.elegans ORF F26E4.b (CEF26E4); 21:Mm_EST[sect][Dagger] M.musculus EST (W54380); 22:Hs_ESTs[sect][Dagger] H.sapiens ESTs (HSA64D051, HSA52B011).

Figure 3 shows new ds RNA binding domain family members from bacteria (9:My_ORF, 10:Cr_ORF, 11:Si_ORF), viruses (68:Va_E3; 33:Rc_NS34; 34:Rs_NS34) and eucarya (yeast 15:Sp_C8A4.08C, 35:Sc_RM03; worm 16:Ce_K12H4.8, 19:Ce_ F26E4.b, 46:Ce_F55A44.1, 47:Ce_F55A44.2, 71:Ce_ZK6322, 72:Ce_ORF.1, 73:Ce_ORF.2, 74:Ce_T07D43.1, 75:Ce_T07D43.2, 76:Ce_T22A3.f; mammals 20:Hs_ESTs, 67:Mm_TENR). The underlined sequences are known RNA binding proteins. Although Paramecium chlorella virus 1 genome contains a protein that is a member of both this and the RNase III family (12:Pc_A464R; 13:Pc_A464R in Fig. 2 ), the new viral members lack a catalytic RNase III-like domain suggesting that this activity may reside in a different protein in variola virus and the rotaviruses. A new eucaryotic member may be a link between transcription and RNA metabolism: 71:Ce_ZK6322 also contains a copy of the forkhead-associated (FHA) domain, a putative nuclear signalling domain found in a variety of otherwise unrelated proteins such as transcription factors and kinases (44 -46 ). A subfamily of the ds RNA binding domain is present in an array of tissue types and has a shorter than average [alpha]1-[beta]1 loop suggesting a common substrate (52:XI_4F1.1, 53:XI_4F1.2, 54:Hs_NF90.1, 55:Hs_NF90.2, 56:Mm_SPNR.1, 57:Mm_SPNR.2, 58:Rn_RED1.1, 59:Rn_ RED1.2). Given the known functions of these members, this substrate could be important in transcription and be a candidate for adenosine to inosine RNA editing.


Figure 3. An HMM-generated multiple sequence alignment of ds RNA-binding domain family members from bacteria [1-11, 13 and 14], viruses [12 and 68-70] and eucarya [all other sequences]. Cylinders and arrows denote the [alpha]-helices and [beta]-strands in the structures of 1:Ec_RNIII (60) and 38:Dm_STAU.3 (61). 1:Ec_RNIII E.coli RNase III (RNC_ECOLI); 2:St_RNIII S.typhimurium RNase III (STU48415); 3:Hi_RNIII H.influenzae RNase III (RNC_HAEIN); 4:Bs_RNIII B.subtilis RNase III (BACORF1G); 5:Cb_RNIII C.burnetii RNase III (COXRER); 6:Rc_RNIII R.capsulatus RNase III (RCLEPRNCG); 7:Mt_RNIII M.tuberculosis RNase III (MTCY338); 8:Mg_RNIII M.genitalium RNase III (RNC_MYCGE); 9:My_ORF[sect] Mycoplasma-like organism ORF (translation of MOU15224); 10:Cr_ORF[sect] C.ruminantium ORF (translation of CRPCS20); 11:Si_ORF[sect] S.citri ORFB (SCU28972); 12:Pc_A464R P.bursaria chlorella virus 1 ORF A464R similar to RNase III (PBU42580); 13:S._RNIII Synechocystis sp.RNase III (SYCSLRB); 14:S._RNIIIb Synechocystis sp.PCC6803 RNase III (D90914); 15:Sp_C8A4.08C[sect] S.pombe hypothetical helicase C8A4.08C (YAH8_SCHPO); 16:Ce_K12H4.8[sect] C.elegans hypothetical helicase K12H4.8 (YM68_CAEEL); 17:Sc_RNT1 S.cerevisiae RNase RNT1 (SCU27016); 18:Sp_PAC1 S.pombe RNase PAC1 (PAC1_SCHPO); 19:Ce_F26E4.b[sect] C.elegans ORF F26E4.b (CEF26E4); 20:Hs_ESTs[sect] H.sapiens ESTs (W60364, R82247); 21:XI_RNPA.1-23:XI_RNPA.3 Xenopus laevis ds RNA-binding protein A (S27945); 24:Hs_TRBP1.1-26:Hs_TRBP1.3 H.sapiens trans-activation-responsive (TAR) RNA-binding protein (A38430); 27:Ms_TIK.1-28:Ms_TIK.2 M.musculus serine/threonine protein kinase TIK (A40813); 29:Hs_P68.1-30:Hs_P68.2 H.sapiens ds RNA-activated protein kinase p68 (KP68_HUMAN); 31:Rn_IF2A.1-32:Rn_IF2A.2 Rattus norvegicus initiation factor 2[alpha] (S50216); 33:Rc_NS34[sect] porcine rotavirus non-structural RNA-binding protein 34 (NS34) (VN34_ROTPC); 34:Rs_NS34[sect] bovine rotavirus NS34 (VN34_ROTBS); 35:Sc_RM03[sect] S.cerevisiae mitochondrial ribosomal protein L3 (RM03_YEAST); 36:Dm_STAU.1-40:Dm_STAU.5 Drosophila melanogaster maternal effect protein staufen (STAU_DROME); 41:Ce_F55A45.1-45:Ce_F55A45.5 C.elegans ORF F55A4.5 similar to staufen (CELF55A4); 46:Ce_F55A44.1[sect]-47:Ce_F55A44.2[sect] C.elegans ORF F55A4.4 (CELF55A4); 48:Dm_MLE.1-49:Dm_MLE.2 D.melanogaster maleless (MLE) required for increased transcription of X-linked genes in males (A40025); 50:Hs_RNHA.1-51:Hs_RNHA.2 H.sapiens RNA helicase A homologous to MLE (RNHA_HUMAN); 52:XI_4F1.1-53:XI_4F1.2 X.laevis ds RNA-binding protein 4F.1 (XLU07155); 54:Hs_NF90.1-55:Hs_NF90.2 H.sapiens NF90, the 90 kDa subunit of cyclosporin A- and FK506-sensitive nuclear transcription factor of activated T-cells (B54857); 56:Mm_SPNR.1-57:Mm_SPNR.2 M.musculus spermatid Spnr localised to cytoplasmic microtubles (MMSPNR); 58:Rn_RED1.1-59:Rn_RED1.2 R.norvegicus brain ds RNA-specific editase (RED1) (RNU43534); 60:Hs_SON H.sapiens son protein (SON_HUMAN); 61:Rn_DRADA.1-63:Rn_DRADA.3 R.norvegicus ds RNA adenosine deaminase (DRADA) (RNU18942); 64:Hs_DRADA.1-66:Hs_DRADA.3 H.sapiens DRADA (HSU10439); 67:Mm_TENR[sect] M.musculus spermatid RNA binding protein Tenr (MMTENR); 68:Va_E3[sect] variola virus protein E3L (VE03_VARV); 69:Vv_E3 vaccinia virus strain WR E3L (VE03_VACCV); 70:Vc_E3 vaccinia virus strain Copenhagen E3L (VE03_VACCC); 71:Ce_ZK6322[sect] C.elegans ORF ZK632.2 (YOT2_CAEEL); 72:Ce_ORF.1[sect]-73:Ce_ORF.2[sect] C.elegans ORF (S42378); 74:Ce_T07D43.1[sect]-75:Ce_T07D43.2[sect] C.elegans ORF T07D4.3 (CET07D4); 76:Ce_T22A3.f[sect] C.elegans ORF T22A3.f (CET22A3).

Figure 4 shows new RNase II family members from bacteria (3:Tf_ORF, 17:S._ZAM) and eucarya (yeast 11:Sc_ORF, 16:Sc_MSU1; malaria parasite 18:Pf_EST; mammal 19:Hs_ESTs). These are candidates for 3' -> 5' nucleases involved in processive RNA degradation and since some of the other yeast members are essential for cell division, they may be important for control of mitosis.


Figure 4. An HMM-generated multiple sequence alignment for RNase II family members from bacteria [1-9 and 17] and eucarya [10-16, 18 and 19]. The location of the PROSITE RNase II signature (RIBONUCLEASE_II) and the pattern itself are indicated. 1:Ec_RN11 E.coli RNase II (RNB_ECOLI); 2:Hi_RNII H.influenzae RNase II (RNB_HAEIN); 3:Tf_ORF[sect][Dagger] Thiobacillus ferrooxidans ORF (S23260); 4:Ec_VACB E.coli vacB (VACB_ECOLI); 5:Hi_VACB H.influenzae vacB (HIU32767); 6:Vp_VACB[Dagger] Vibrio parahaemolyticus vacB (VACB_VIBPA); 7:Sf_VACB Shigella flexneri vacB required for posttranscriptional expression of virulence genes on the large plasmid (VACB_SHIFL); 8:S._RNII Synechocystis sp.PCC6803 RNase II (D90904); 9:Mg_VACB M.genitalium vacB (MGU39690); 10:Sp_DIS3 S.pombe mitotic control protein dis3 (DIS3_SCHPO); 11:Sc_ORF[sect] S.cerevisiae ORF YOL021c (SCYOL021C); 12:Ce_DIS3 C.elegans ORF C04G2.6 similar to dis3 (CEC04G2); 13:Sc_SSD1 S.cerevisiae cell cycle control protein SSD1/SRK1 (SSD1_YEAST); 14:Ce_SSD1 C.elegans ORF F48E8.6 similar to SSD1 (CELF48E8); 15:Nc_CYT4 Neurospora crassa mitochondrial RNA-splicing regulatory protein phosphatase CYT-4 (A38227); 16:Sc_MSU1[sect] S.cerevisiae MSU1 essential for mitochondrial biogenesis (MSU1_YEAST); 17:S._ZAM[sect] Synechocystis sp.PCC6803 protein zam which controls resistance to the carbonic anhydrase inhibitor acetazolamide (S46946); 18:Pf_EST[sect][Dagger] Plasmodium falciparum EST (N97483); 19:Hs_ESTs[sect][Dagger] H.sapiens ESTs (HSA63B121, W38990, HSA54A071).

Figure 5 shows that RNase PH sequences comprise a complete domain that is also present in PNPase from bacteria (11:Ec_PNPase, 12:PI_PNPase, 13:Hi_PNPase, 14:Bs_PNPase, 15:S._PNPase, 17:Sa_GPS) and eucarya (16:So_PNPase). A number of eucaryotic sequences also possess this domain and are thus members of the RNase PH family (yeast 9:Sc_YG87, 18:Sc_YGR095C, 20:Sc_ORF2315, 21:Sp_YAXE, 23:Sc_D99541; worm 19:Ce_C14A45, 24:Ce_F37C1213; plant 26:Zm_EST; mammals 22:Hs_ORF, 25:Hs_PMSC75, 27:Mm_ESTs, 28:Hs_ESTs). Since both RNase PH and PNPase are 3' -> 5' phosphorolytic nucleases, the presence of a common domain suggests that they may have a similar structure and/or mechanism of action. PNPase has been shown to be involved in 3' adenylation-mediated degradation of mRNA (47 ). A multiprotein complex mediating mRNA degradation in E.coli and including at least PNPase has been proposed (48 ). Since RNase PH can catalyse the phosphorolytic cleavage of poly(A) (16 ), it may be a part of this processing complex and thus involved in coordinated control of mRNA degradation. Given that this RNase PH domain is present in a variety of both bacterial and eucaryotic proteins, control of mRNA degradation in these two kingdoms may be similar. Of particular interest is the human protein 25:Hs_PMSC75, one of two antigenically unrelated proteins recognised by sera from patients suffering from the polymyositis/scleroderma overlap syndrome (PMSCL) and which is defined by idiopathic chronic inflammation in skeletal muscle (reviewed in 49 ). These 75 and 100 kDa autoantigens, part of a particle localised in the granular component of the nucleolus, belong to the RNase PH and D familes, respectively, suggesting that aberrant RNA processing may be a factor in PMSCL. The role(s) of the other human RNase PH members in this and other disorders remains to be seen.


Figure 5. An HMM-generated multiple sequence alignment of RNase PH family members from bacteria [1-8 and 11-15] and eucarya [9, 10 and 16-28]. 1:Ec_RNPH E.coli RNase PH (RNPH_ECOLI); 2:St_RNPH[Dagger] S.typhimurium RNase PH (RNPH_SALTY); 3:Bs_RNPH B.subtilis RNase PH (RNPH_BACSU); 4:Hi_RNPH H.influenzae RNase PH (RNPH_HAEIN); 5:MI_RNPH Mycobacterium leprae RNase PH (RNPH_MYCLE); 6:Mt_RNPH M.tuberculosis RNase PH (MTCY130); 7:Cc_RNPH C.crescentus (CCU33324); 8:Pa_RNPH Pseudomonas aeruginosa RNase PH (PAU38241); 9:Sc_YG87[sect] S.cerevisiae ORF YG87 (YG87_YEAST); 10:Ce_RNPH C.elegans RNase PH (CEB0564); 11:Ec_PNPase[sect] E.coli PNPase (PNP_ECOLI); 12:PI_PNPase[sect] Photorhabdus luminescens PNPase (PNP_PHOLU); 13:Hi_PNPase[sect] H.influenzae PNPase, (PNP_HAEIN); 14:Bs_PNPase[sect] B.subtilis PNPase (BSU29668); 15:S._PNPase[sect] Synechocystis sp. PCC6803 PNPase (D90899); 16:So_PNPase[sect] Spinacia oleracea PNPase (SOU52048); 17:Sa_GPS[sect] Streptomyces antibioticus guanosine pentaphosphate synthetase which has shown to be a PNPase (62) (SAU19858); 18:Sc_YGR095C[sect] S.cerevisiae ORF YGR095c (SCYGR095C); l9:Ce_C14A45[sect] C.elegans ORF C14A4.5 (CEC14A4); 20:Sc_ORF2315[sect] S.cerevisiae ORF 2315 (SCCHRIVLA); 21:Sp_YAXE[sect] S.pombe ORF YAXE (YAXE_SCHPO); 22:Hs_ORF[curren] H.sapiens ORF (HUMORFA10); 23:Sc_D99541[sect] S.cerevisiae ORF D9954.1 (YSCD9954); 24:Ce_F37C1213[sect] C.elegans ORF F37C12.13 (CELF37C12); 25:Hs_PMSC75[sect] H.sapiens 75 kDa polymyositis/scleroderma overlap syndrome (PMSCL) autoantigen (JH0446); 26:Zm_EST[Dagger] Zea mays RNase PH EST (T18324); 27:Mm_ESTs[sect][Dagger] M.muscu1us ESTs (AA000401, W14321); 28:Hs_ESTs[sect][Dagger] H.sapiens ESTs (W58718, HSPD03858).


Figure 6. An HMM-generated multiple sequence alignment for the RNase D family. Cylinders and arrows denote the [alpha]-helices and [beta]-strands in the structure of 14:Ec_DPOL1 (63-65). 1:Ec_RND E.coli RNase D (RND_ECOLI); 2:Hi_RND H.influenzae RNase D (RND_HAEIN); 3:MI_U1764U[sect] M.leprae ORF U1764U (MLU15181); 4:Dn_ORFQ[sect][Dagger] Dichelobacter nodosus ORFQ (DNU17138); 5:S._sII0320[sect][Dagger] Synechocystis sp. PCC6803 ORF sII0320 (SYCSLRB); 6:Sp_SPAC1F301[sect] S.pombe ORF SPAC1F3.01 (SPAC1F3); 7:Sc_UNC733[sect] S.cerevisiae ORF UNC733 (SCU43491); 8:Ce_C14A44[sect] C.elegans ORF C14A4.4 similar to PMSCL autoantigen (CEC14A4); 9:Hs_PMSC100[sect] H.sapiens 100 kDa PMSCL autoantigen (PMSC_HUMAN); 10:Ce_ZK10988[sect] C.elegans ORF ZK1098.8 (YO68_CAEEL); 11:Ce_ZK10983[sect] C.elegans ORF ZK1098.3 (YO63_CAEEL); 12:Hs_WRN[sect] H.sapiens Werner syndrome protein (WRN) (HUMDR); 13:Hi_DPOL1[sect] H.influenzae DNA polymerase I (DPO1_HAEIN); 14:Ec_DPOL1[sect] E.coli DNA polymerase I (DPO1_ECOLI); 15:RI_DPOL1[sect] Rhizobium leguminosarum DNA polymerase I (S43892); 16:S._DPOL1[sect] Synechocystis sp.PCC6803 DNA polymerase I (SYCSLRG); 17:X_G1253123[sect] sequence 12 from patent US 5466591 (1253123); 18:X_G1253119[sect] sequence 4 from patent US 5466591 (1253119); 19:Tp_DPOL1[sect] Treponema pallidum DNA polymerase I (TPU57757); 20:T5_DPOL[sect] bacteriophage T5 DNA polymerase (DPOL_BPT5); 21:SP01_DPOL[sect] bacteriophage SP01 DNA polymerase (DPOL_BPSP1); 22:ML5_DPOL[sect] Mycobacteriophage L5 DNA polymerase (DPOL_BPML5); 23:C31_ORF[sect] Phage [Phi]-C31 ORF11 (S38923).

Figure 6 shows new RNase D family members from bacteria (3:MI_U1764U, 4:Dn_ORFQ, 5:S._sII0320). These RNase D sequences comprise a complete domain that is also present in eucaryotic proteins (yeast 6:Sp_SPAC1F301, 7:Sc_UNC733; worm 8:Ce_C14A44, 10:Ce_ZK10988, 11:Ce_ZK10983; mammals 9:Hs_PMSC100, 12:Hs_WRN). This RNase D domain is itself similar to the proofreading 3' -> 5' nuclease domain found in many DNA polymerases (14:Ec_DPOL1-23:C31_ORF are selected sequences from this family). Following this putative exoribonuclease domain is a region not present in the DNA proofreading enzymes. Given the nucleolar location of the 100 kDa PMSCL autoantigen (9:Hs_PMSC100), the particle of which it is a component may be involved in pre-rRNA processing. Werner syndrome is a rare autosomal recessive disorder that mimics some of the characteristics of many age-related features (reviewed in 50 ). The Werner syndrome protein (WRN) contains a recQ class helicase domain suggesting possible involvement in nucleotide excision repair and transcription (51 ). The RNase D domain in WRN suggests that it could act upon RNA also and possibly have a role in processing heterogeneous nuclear RNA. How and whether the helicase and 3' -> 5' exoribonuclease domains interact and their role(s) in aging remain to be determined.

The RNase D family not only possesses the three motifs characteristic of the DNA proofreading enzymes (52 ) (Exo I, Exo II and Exo III in Fig. 6 ), but also shares a number of conserved residues outside these motifs. Since the three-dimensional structure of the 3' -> 5' exodeoxyribonuclease domain of E.coli Klenow fragment is known, the RNase D family is predicted to possess a similar structure. The structure of the Klenow fragment (14:Ec_DPOL1 in Fig. 6 ) resembles closely the corresponding region in the T4 DNA polymerase despite limited sequence identify (53 ). In both cases, the side chains of four negatively charged residues that serve as ligands for the two metal ions required for catalysis are located in geometrically equivalent positions. These charged residues correspond to four of the five invariant residues in the RNase D family, whilst the fifth corresponds to catalytically active tyrosine (Tyr). This suggests that a 3' -> 5' exoribonuclease has a mechanism of action and active site structure similar to a 3' -> 5' exodeoxyribonuclease. Thus, mutations at the invariant positions that affect 3' -> 5' nuclease activity in DNA proofreading enzymes (reviewed in 54 ) may have a similar effect on the RNase D family.

Comparative examination of all the families indicates that each possesses at least one invariant Asp and/or Glu, amino acids implicated in metal complex-promoted phosphodiester bond hydrolysis in a number of RNases. For example, RNase PH (17 ) and S.cerevisiae pac1 RNase (RNase III family) (55 ) require divalent metal ions for activity. A single magnesium (Mg2+) ion-binding site containing a Glu that ligates the metal ion is essential for RNase HI catalytic activity (56 ). Escherichia coli RNase H, reverse transcriptase and reverse transcriptase-like entities in eucaryotic genomes (57 ), possess four invariant acidic residues of which at least three are involved in Mg2+ binding in RNase H (58 ). Thus, invariant negatively charged residues could be metal ion ligands important for catalytic activity and/or necessary for stabilising local RNA conformation. In the RNase HII and PH families, invariant Lys, Arg and serine (Ser) may interact with key phosphate groups and/or bases in the substrate. Invariant Gly and Pro in the RNase HII, III and II families could be structurally important whereas invariant Leu and Val residues in the first two of the aforementioned RNases may participate in substrate recognition. By analogy with the RNase D family, the invariant Tyr in RNase II may be an active site residue that interacts with the scissile phosphate of the mRNA substrate. Although invariant and other conserved residues are scattered throughout the primary sequences of the families, folding of the RNases may juxtapose them to form a metal ion-containing active site. Finally, reversible phosphorylation of residues situated in the substrate binding site may be a means to regulate these RNases and the pathways in which they act. Thus, phosphorylation of such Ser, Thr and Tyr residues could lower affinity for RNA by increasing electrostatic repulsion between the phosphate backbone and the phosphorylated amino acid.

ACKNOWLEDGEMENTS

This work was supported by NIH grant number GM17129 and by the Director, Office of Energy Research, Office of Health and Environmental Research, Division of the US Department of Energy under Contract No. DE-AC03-76F00098. The data and multiple alignments are available in electronic form upon request.

REFERENCES

1 Schmid,H., Pouch,M., Petit,F., Dadet,M., Badaoui,S., Boissonnet,G., Buri,J., Norris,V. and Briand,Y. (1995) Mol. Biol. Rep.,21, 43-47. MEDLINE Abstract

2 Deutscher,M. (1993) J. Biol. Chem.,268, 13011-13014. MEDLINE Abstract

3 Apirion,D. and Miczak,A. (1993) Bioessays, 15, 113-120. MEDLINE Abstract

4 Rost,B. (1995) Intelligent Systems Mol. Biol.3, 314-321.

5 Golz,J., Clarke,A. and Newbigin,E. (1995) Curr. Opin. Genet. Dev.,5, 640-645. MEDLINE Abstract

6 Kao,T. and McCubbin,A. (1996) Proc. Natl. Acad. Sci. USA,93, 12059-12065. MEDLINE Abstract

7 Krogh,A., Brown,M., Mian,I.S., Sjölander,K. and Haussler,D. (1994) J. Mol. Biol.,235, 1501-1531. MEDLINE Abstract

8 Baldi,P., Chauvin,Y., Hunkapiller,T. and McClure,M. (1994) Proc. Natl. Acad. Sci. USA,91, 1059-1063. MEDLINE Abstract

9 Eddy,S. (1996) Curr. Opin. Struct. Biol., 6, 361-365. MEDLINE Abstract

10 Fujiwara,Y., Asogawa,M. and Konagaya,A. (1994) Intelligent Systems Mol. Biol.2, 121-129.

11 Li,Z. and Deutscher,M. (1994) J. Biol. Chem.,269, 6064-6071. MEDLINE Abstract

12 Reuven,N. and Deutscher,M. (1993) FASEB J., 7, 143-148. MEDLINE Abstract

13 Tomasiewicz,H. and McHenry,C. (1987) J. Bacteriol.,169, 5735-5744. MEDLINE Abstract

14 Itaya,M. (1990) Proc. Natl. Acad. Sci. USA,87, 8587-8591. MEDLINE Abstract

15 Elela,S., Igel,H. and Ares,M.,Jr (1996) Cell,85, 115-124. MEDLINE Abstract

16 Jensen,K.F., Andersen,J.T. and Poulsen,P. (1992) J. Biol. Chem.,267, 17147-17152. MEDLINE Abstract

17 Kelly,K.O. and Deutscher,M.P. (1992) J. Biol. Chem.,267, 17153-17158. MEDLINE Abstract

18 Coburn,G. and Mackie,G. (1996) J. Biol. Chem.,271, 15776-15781. MEDLINE Abstract

19 Zhang,J. and Deutscher,M. (1988) J. Biol. Chem.,263, 17909-17912. MEDLINE Abstract

20 Putnam,D. (1996) Am. J. Health-System Pharmacy, 53, 151-160.

21 Wang,J., Qiu,L., Wu,E. and Drlica,K. (1996) J. Bacteriol.,178, 1640-1645. MEDLINE Abstract

22 Pepe,C., Maslesa-Galic,S. and Simons,R. (1994) Mol. Microbiol.,13, 1133-1142. MEDLINE Abstract

23 Altschul,S., Gish,W., Miller,W., Myers,E. and Lipman,D. (1990) J. Mol. Biol.,215, 403-410. MEDLINE Abstract

24 Hughey,R. and Krogh,A. (1996) Comp. Appl. Biosci.,12, 95-107. The hidden Markov model software can be accessed from http://www.cse.ucsc.edu/research/compbio/sam.html. MEDLINE Abstract

25 Brown,M., Hughey,R., Krogh,A., Mian,I., Sjölander,K. and Haussler,D. (1993) Intelligent Systems Mol. Biol. 1, 47-55.

26 Sjölander,K., Karplus,K., Brown,M., Hughey,R., Krogh,A., Mian,I. and Haussler,D. (1996) Comp. Appl. Biosci.,12, 327-345. MEDLINE Abstract

27 Altschul,S. (1991) J. Mol. Biol., 219, 555-565. MEDLINE Abstract

28 Barrett,C., Hughey,R. and Karplus,K. (1997) Comp. Appl. Biosci.,13, 191-199. MEDLINE Abstract

29 NCI (1996) NRP (Non-Redundant Protein) and NRN (Non-Redundant Nucleic Acid) Database. Distributed on the Internet via anonymous FTP from ftp.ncifcrf.gov, under the auspices of the National Cancer Institute's Frederick Biomedical Supercomputing Center.

30 Barton,G. (1993) Protein Engng,6, 37-40. MEDLINE Abstract

31 Rotondo,G., Gillespie,M. and Frendewey,D. (1995) Mol. Gen. Genet.,247, 698-708. MEDLINE Abstract

32 Kutish,G., Li,Y., Lu,Z., Furuta,M., Rock,D.L. and Van Etten,J. (1996) Virology,223, 303-317. MEDLINE Abstract

33 St. Johnston,D., Brown,N., Gall,J. and Jantsch,M. (1992) Proc. Natl. Acad. Sci. USA, 89, 10979-10983.

34 Gatignol,A., Buckler,C. and Jeang,K. (1993) Mol. Cell. Biol.,13, 2193-2202. MEDLINE Abstract

35 Zilhao,R., Camelo,L. and Arraiano,C. (1993) Mol. Microbiol., 8, 43-51. MEDLINE Abstract

36 Tobe,T., Sasakawa,C., Okada,N., Honma,Y. and Yoshikawa,M. (1992) J. Bacteriol., 174, 6359-6367. MEDLINE Abstract

37 Kinoshita,N., Goebl,M. and Yanagida,M. (1991) Mol. Cell. Biol., 11, 5839-5847. MEDLINE Abstract

38 Sutton,A., Immanuel,D. and Arndt,K. (1991) Mol. Cell. Biol., 11, 2133-2148. MEDLINE Abstract

39 Wilson,R., Brenner,A., White,T., Engler,M., Gaughran,J. and Tatchell,K. (1991) Mol. Cell. Biol., 11, 3369-3373. MEDLINE Abstract

40 Turcq,B., Dobinson,K., Serizawa,N. and Lambowitz,A. (1992) Proc. Natl. Acad. Sci. USA, 89, 1676-1680. MEDLINE Abstract

41 Bult,C., White,O., Olsen,G., Zhou,L., Fleischmann,R., Sutton,G., Blake,J., FitzGerald,L., Clayton,R., Gocayne,J. et al. (1996) Science,273, 1058-1073. MEDLINE Abstract

42 Davidov,Y., Rahat,A., Flechner,I. and Pines,O. (1993) J. Gen. Microbiol., 139, 717-724. MEDLINE Abstract

43 Li,H. and Nicholson,A. (1996) EMBO J., 15,1421-1433. MEDLINE Abstract

44 Hofmann,K. and Bucher,P. (1995) Trends Biochem. Sci., 20, 347-349. MEDLINE Abstract

45 Stone,J., Collinge,M., Smith,R., Horn,M. and Walker,J. (1994) Science, 266, 793-795. MEDLINE Abstract

46 Navas,T., Zhou,Z. and Elledge,S. (1995) Cell, 80, 29-39. MEDLINE Abstract

47 Xu,F. and Cohen,S. (1995) Nature, 374, 180-183. MEDLINE Abstract

48 Py,B., Causton,H., Mudd,E. and Higgins,C. (1994) Mol. Microbiol., 14, 717-729. MEDLINE Abstract

49 Plotz,P., Rider,L., Targoff,I., Raben,N., O'Hanlon,T. and Miller,F. (1995) Ann. Internal Med., 122, 715-724.

50 Epstein,C. and Motulsky,A. (1996) Bioessays, 18, 1025-1027. MEDLINE Abstract

51 Yu,C., Oshima,J., Fu,Y., Wijsman,E., Hisama,F., Alisch,R., Matthews,S., Nakura,J., Miki,T., Ouais,S., Martin,G., Mulligan,J. and Schellenberg,G. (1996) Science, 272, 258-262. MEDLINE Abstract

52 Bernad,A., Blanco,L., Lazaro,J., Martin,G. and Salas,M. (1989) Cell, 59, 219-228. MEDLINE Abstract

53 Wang,J., Yu,P., Lin,T., Konigsberg,W. and Steitz,T. (1996) Biochemistry, 35, 8110-8119. MEDLINE Abstract

54 Joyce,C. and Steitz,T. (1994) Annu. Rev. Biochem., 63, 777-822. MEDLINE Abstract

55 Rotondo,G. and Frendewey,D. (1996) Nucleic Acids Res., 24, 2377-2386. MEDLINE Abstract

56 Katayanagi,K., Okumura,M. and Morikawa,K. (1993) Proteins, 17, 337-346. MEDLINE Abstract

57 Doolittle,R., Feng,D., Johnson,M. and McClure,M. (1989) Q. Rev. Biol., 64, 1-30. MEDLINE Abstract

58 Katayanagi,K., Miyagawa,M., Matsushima,M., Ishikawa,M., Kanaya,S., Nakamura,H., Ikehara,M., Matsuzaki,T. and Morikawa,K. (1992) J. Mol. Biol., 223, 1029-1052. MEDLINE Abstract

59 Briggs,M., Dacanay,K. and Butler,J. (1997) Mol. Cell. Biol., in press.

60 Kharrat,A., Macias,M., Gibson,T., Nilges,M. and Pastore,A. (1995) EMBO J., 14, 3572-3584. MEDLINE Abstract

61 Bycroft,M., Grünert,S., Murzin,A., Proctor,M. and St Johnston,D. (1995) EMBO J., 14, 3563-3571. MEDLINE Abstract

62 Jones,G. and Bibb,M. (1996) J. Bacteriol., 178, 4281-4288. MEDLINE Abstract

63 Derbyshire,V., Freemont,P., Sanderson,M., Beese,L., Friedman,J., Joyce,C. and Steitz,T. (1988) Science, 240, 199-201. MEDLINE Abstract

64 Beese,L. and Steitz,T. (1991) EMBO J., 10, 25-33. MEDLINE Abstract


*Address correspondence to author at: Life Sciences Division (Mail Stop 29-100), Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA 94720, USA. Tel: +1 510 486 6216; Fax: +1 510 486 6949; Email: smian@lbl.gov
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. Barbas, R. G. Matos, M. Amblar, E. Lopez-Vinas, P. Gomez-Puertas, and C. M. Arraiano
New Insights into the Mechanism of RNA Degradation by Ribonuclease II: IDENTIFICATION OF THE RESIDUE RESPONSIBLE FOR SETTING THE RNase II END PRODUCT
J. Biol. Chem., May 9, 2008; 283(19): 13070 - 13076.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. A. Harrigan, J. Piotrowski, L. Di Noto, R. L. Levine, and V. A. Bohr
Metal-catalyzed Oxidation of the Werner Syndrome Protein Causes Loss of Catalytic Activities and Impaired Protein-Protein Interactions
J. Biol. Chem., December 14, 2007; 282(50): 36403 - 36411.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
M. Amblar, A. Barbas, P. Gomez-Puertas, and C. M. Arraiano
The role of the S1 domain in exoribonucleolytic activity: Substrate specificity and multimerization
RNA, March 1, 2007; 13(3): 317 - 327.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Tomaru, T. Satoh, S. Yoshino, T. Ishizuka, K. Hashimoto, T. Monden, M. Yamada, and M. Mori
Isolation and Characterization of a Transcriptional Cofactor and Its Novel Isoform that Bind the Deoxyribonucleic Acid-Binding Domain of Peroxisome Proliferator-Activated Receptor-{gamma}
Endocrinology, January 1, 2006; 147(1): 377 - 388.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
R. Seal, R. Temperley, J. Wilusz, R. N. Lightowlers, and Z. M. A. Chrzanowska-Lightowlers
Serum-deprivation stimulates cap-binding by PARN at the expense of eIF4E, consistent with the observed decrease in mRNA stability
Nucleic Acids Res., January 14, 2005; 33(1): 376 - 387.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-G. Ren, L. A. Kirsebom, and A. Virtanen
Coordination of Divalent Metal Ions in the Active Site of Poly(A)-specific Ribonuclease
J. Biol. Chem., November 19, 2004; 279(47): 48702 - 48706.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
J. L. Penschow, D. A. Sleve, C. M. Ryan, and L. K. Read
TbDSS-1, an Essential Trypanosoma brucei Exoribonuclease Homolog That Has Pleiotropic Effects on Mitochondrial RNA Metabolism
Eukaryot. Cell, October 1, 2004; 3(5): 1206 - 1216.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
L. S. Harlow, A. Kadziola, K. F. Jensen, and S. Larsen
Crystal structure of the phosphorolytic exoribonuclease RNase PH from Bacillus subtilis and implications for its quaternary structure and tRNA binding
Protein Sci., March 1, 2004; 13(3): 668 - 677.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Plchova, F. Hartung, and H. Puchta
Biochemical Characterization of an Exonuclease from Arabidopsis thaliana Reveals Similarities to the DNA Exonuclease of the Human Werner Syndrome Protein
J. Biol. Chem., November 7, 2003; 278(45): 44128 - 44138.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
S. PHILLIPS and J. S. BUTLER
Contribution of domain structure to the RNA 3' end processing and degradation functions of the nuclear exosome subunit Rrp6p
RNA, September 1, 2003; 9(9): 1098 - 1107.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Ishii, O. Nureki, and S. Yokoyama
Crystal Structure of the tRNA Processing Enzyme RNase PH from Aquifex aeolicus
J. Biol. Chem., August 22, 2003; 278(34): 32397 - 32404.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Raijmakers, W. V. Egberts, W. J. van Venrooij, and G. J. M. Pruijn
The Association of the Human PM/Scl-75 Autoantigen with the Exosome Is Dependent on a Newly Identified N Terminus
J. Biol. Chem., August 15, 2003; 278(33): 30698 - 30704.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. A. Harrigan, P. L. Opresko, C. von Kobbe, P. S. Kedar, R. Prasad, S. H. Wilson, and V. A. Bohr
The Werner Syndrome Protein Stimulates DNA Polymerase {beta} Strand Displacement Synthesis via Its Helicase Activity
J. Biol. Chem., June 13, 2003; 278(25): 22686 - 22695.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
B. Wang, N. L. Ernst, S. S. Palazzo, A. K. Panigrahi, R. Salavati, and K. Stuart
TbMP44 Is Essential for RNA Editing and Structural Integrity of the Editosome in Trypanosoma brucei
Eukaryot. Cell, June 1, 2003; 2(3): 578 - 587.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
I. Calin-Jageman and A. W. Nicholson
RNA structure-dependent uncoupling of substrate recognition and cleavage by Escherichia coli ribonuclease III
Nucleic Acids Res., May 1, 2003; 31(9): 2381 - 2392.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
A. K. PANIGRAHI, A. SCHNAUFER, N. L. ERNST, B. WANG, N. CARMEAN, R. SALAVATI, and K. STUART
Identification of novel components of Trypanosoma brucei editosomes
RNA, April 1, 2003; 9(4): 484 - 492.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Dziembowski, J. Piwowarski, R. Hoser, M. Minczuk, A. Dmochowska, M. Siep, H. van der Spek, L. Grivell, and P. P. Stepien
The Yeast Mitochondrial Degradosome. ITS COMPOSITION, INTERPLAY BETWEEN RNA HELICASE AND RNase ACTIVITIES AND THE ROLE IN MITOCHONDRIAL RNA METABOLISM
J. Biol. Chem., January 10, 2003; 278(3): 1603 - 1611.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
T. A. Golden, S. E. Schauer, J. D. Lang, S. Pien, A. R. Mushegian, U. Grossniklaus, D. W. Meinke, and A. Ray
Short Integuments1/suspensor1/carpel Factory, a Dicer Homolog, Is a Maternal Effect Gene Required for Embryo Development in Arabidopsis
Plant Physiology, October 1, 2002; 130(2): 808 - 822.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-G. Ren, J. Martinez, and A. Virtanen
Identification of the Active Site of Poly(A)-specific Ribonuclease by Site-directed Mutagenesis and Fe2+-mediated Cleavage
J. Biol. Chem., February 15, 2002; 277(8): 5982 - 5987.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Machwe, L. Xiao, S. Theodore, and D. K. Orren
DNase I Footprinting and Enhanced Exonuclease Function of the Bipartite Werner Syndrome Protein (WRN) Bound to Partially Melted Duplex DNA
J. Biol. Chem., February 1, 2002; 277(6): 4492 - 4504.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M.-C. Daugeron, F. Mauxion, and B. Seraphin
The yeast POP2 gene encodes a nuclease involved in mRNA deadenylation
Nucleic Acids Res., June 15, 2001; 29(12): 2448 - 2455.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
I. Calin-Jageman, A. K. Amarasinghe, and A. W. Nicholson
Ethidium-dependent uncoupling of substrate binding and cleavage by Escherichia coli ribonuclease III
Nucleic Acids Res., May 1, 2001; 29(9): 1915 - 1925.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
Y. Zuo and M. P. Deutscher
Exoribonuclease superfamilies: structural analysis and phylogenetic distribution
Nucleic Acids Res., March 1, 2001; 29(5): 1017 - 1026.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Xia, Y. Peng, I. S. Mian, and N. F. Lue
Identification of Functionally Important Domains in the N-Terminal Region of Telomerase Reverse Transcriptase
Mol. Cell. Biol., July 15, 2000; 20(14): 5196 - 5207.
[Abstract] [Full Text]


Home page
Nucleic Acids ResHome page
A. Machwe, R. Ganunis, V. A. Bohr, and D. K. Orren
Selective blockage of the 3'->5' exonuclease activity of WRN protein by certain oxidative modifications and bulky lesions in DNA
Nucleic Acids Res., July 15, 2000; 28(14): 2762 - 2770.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
C. Allmang, P. Mitchell, E. Petfalski, and D. Tollervey
Degradation of ribosomal RNA precursors by the exosome
Nucleic Acids Res., April 15, 2000; 28(8): 1684 - 1691.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. T. D. Burkard and J. S. Butler
A Nuclear 3'-5' Exonuclease Involved in mRNA Degradation Interacts with Poly(A) Polymerase and the hnRNA Protein Npl3p
Mol. Cell. Biol., January 15, 2000; 20(2): 604 - 616.
[Abstract] [Full Text]